Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-06 @ 1:34 PM
Study NCT ID:
NCT02652767
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2016-01-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
Sponsor:
GenSight Biologics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GS-LHON-CLIN-03A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None